IBALX
Price
$35.96
Change
+$0.15 (+0.42%)
Updated
Aug 8 closing price
Net Assets
1.45B
RLBCX
Price
$36.91
Change
+$0.12 (+0.33%)
Updated
Aug 8 closing price
Net Assets
253.84B
Interact to see
Advertisement

IBALX vs RLBCX

Header iconIBALX vs RLBCX Comparison
Open Charts IBALX vs RLBCXBanner chart's image
Transamerica Multi-Managed Balanced A
Price$35.96
Change+$0.15 (+0.42%)
VolumeN/A
Net Assets1.45B
American Funds American Balanced R3
Price$36.91
Change+$0.12 (+0.33%)
VolumeN/A
Net Assets253.84B
IBALX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
IBALX vs. RLBCX commentary
Aug 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IBALX is a StrongBuy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 254B vs. IBALX (1.45B). RLBCX (1.56) and IBALX (1.49) have matching dividends . IBALX was incepted earlier than RLBCX: IBALX (31 years) vs RLBCX (23 years). IBALX (0.97) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. IBALX (41.00). RLBCX has a lower initial minimum investment than IBALX: RLBCX (250) vs IBALX (1000). RLBCX annual gain was more profitable for investors over the last year : 9.77 vs. IBALX (5.83). RLBCX return over 5 years is better than : 35.23 vs. IBALX (21.52).
IBALXRLBCXIBALX / RLBCX
Total Expense Ratio0.970.89109%
Annual Report Gross Expense Ratio0.970.89109%
Fund Existence31 years23 years-
Gain YTD6.5698.71275%
Front Load6%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B254B1%
Annual Yield % from dividends1.491.5696%
Returns for 1 year5.839.7760%
Returns for 3 years21.5330.6670%
Returns for 5 years21.5235.2361%
Returns for 10 years52.7861.9585%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DAWN6.100.07
+1.16%
Day One Biopharmaceuticals
MSPR0.750.01
+0.78%
MSP Recovery Inc
ASTC5.370.02
+0.37%
Astrotech Corp
HELE21.81-0.18
-0.82%
Helen of Troy Limited
FDS382.43-4.24
-1.10%
Factset Research Systems